Xeris Pharmaceuticals | XERS - Des Atouts

Prix De L'Action
5.60
Variation Quotidienne
-0.21 -3.61%
Mensuellement
-22.44%
Annuel
22.00%
Q1 Prévisions
5.63




Des Atouts Changement Date
Celltrion KRW 21.08T 530.63B 2025-09
Cspc Pharmaceutical CNY 46B 1.61B 2025-06
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Eli Lilly USD 112.48B 2.46B 2025-12
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 562.21M 2.4M 2025-09
Ovoca Bio EUR 11.41M 3.36M 2022-06
Pacira USD 1.26B 32.66M 2025-12
Perrigo USD 8.54B 1.55B 2025-12
Pharma Mar EUR 395.08M 53.42M 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Sartorius EUR 9.61B 413.4M 2025-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Tilray USD 2.07B 1.33B 2025-03
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09